Skip to main content
. Author manuscript; available in PMC: 2014 Jul 22.
Published in final edited form as: Immunogenetics. 2013 Feb 17;65(5):387–396. doi: 10.1007/s00251-013-0678-9

Fig. 6.

Fig. 6

Somatic mutation in medaka VL- The percentage of mutations in framework (FR) and complementary determining regions (CDR) from 13 representative ESTs are shown. The CDR3 was excluded from the analysis